As of Aug 23
| -0.15 / -0.46%|
The 2 analysts offering 12-month price forecasts for Natus Medical Inc have a median target of 48.00, with a high estimate of 55.00 and a low estimate of 41.00. The median estimate represents a +49.07% increase from the last price of 32.20.
The current consensus among 4 polled investment analysts is to Buy stock in Natus Medical Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.